Sanofi
SNW.DE News Today: Stay Updated with the Latest Sanofi News in Real Time
Find SNW.DE news now at Meyka AI. Stay informed with the latest Sanofi stocks updates, including price news, market analysis, and expert insights.
IPH.PA stock surges 13.7% on April 14 as biotech gains momentum
IPH.PA stock jumps 13.7% to €1.36 on EURONEXT. Innate Pharma gains as biotech sector shows strength with clinical pipeline progress.
GV.PA Stock Surges 5.88% on April 14: Genomic Vision SA Trading Activity Peaks
GV.PA stock rises 5.88% intraday on EURONEXT. Genomic Vision SA shows elevated trading volume of 38.49M shares amid healthcare sector volatility.
RVMD Outperform Rating Maintained by Oppenheimer April 2026
Oppenheimer maintains Outperform rating on RVMD, raises price target to $165 from $150. Stock up 41% year-to-date.
SNY Analyst Rating Maintained by Citigroup April 2026
Citigroup maintains neutral SNY analyst rating, raises price target to EUR 82 on April 13, 2026.
SNY Stock Today: April 12 vYF Trial Matches YF-VAX, Easing Supply Risk
Sanofi vYF matched YF‑VAX in phase 2, signaling relief for yellow fever vaccine supply shortages. See how this de‑risks SNY, U.S. demand drivers, pricing, and key stock metrics.
LHA.DE Stock Today: April 9 Cost Risks Put Lufthansa Margins on Watch
Lufthansa stock today: Onvista flags rising cost risks that could pressure margins. See price levels, valuation, and what to watch into May 6 earnings for LHA.DE.
IPH.PA Innate Pharma (EURONEXT): 55% revenue drop before 26 Mar 2026 results, runway risk
Intraday earnings spotlight on IPH.PA stock: Q4 sales -55% and cash runway update for 26 Mar 2026
IPH.PA Innate Pharma S.A. EURONEXT 24 Mar 2026 intraday: earnings preview ahead
Earnings preview for IPH.PA stock on EURONEXT intraday 24 Mar 2026 ahead of Q1 results and clinical catalysts
CHF80.61 Nestlé (NESN.SW) pre-market on SIX: most active stock, monitor volume
Pre-market update: NESN.SW stock at CHF80.61 on SIX with heavy volume and Meyka AI forecast guidance